Suppr超能文献

髋关节佩特兹病的治疗结果:核心结局集开发的研究方案

The outcomes of Perthes' disease of the hip: a study protocol for the development of a core outcome set.

作者信息

Leo Donato Giuseppe, Leong Wei Yee, Gambling Tina, Long Andrew, Murphy Rebecca, Jones Helen, Perry Daniel Christopher

机构信息

School of Sport & Exercise Sciences, Liverpool John Moores University, Liverpool, UK.

Alder Hey Children's Hospital, Prescott Road, Liverpool, L14 2AB, UK.

出版信息

Trials. 2018 Jul 13;19(1):374. doi: 10.1186/s13063-018-2695-3.

Abstract

BACKGROUND

Perthes' disease is an idiopathic osteonecrosis of a developmental hip that is most frequent in Northern Europe. Currently, the absence of a common set of standardised outcomes makes comparisons between studies of different interventions challenging. This study aims to summarise the outcomes used in clinical research of interventions for Perthes' disease and define a set of core outcomes (COS) to ensure that the variables of primary importance are measured and reported in future research studies investigating Perthes' disease.

METHODS

A systematic review of the current literature will be used to identify a list of outcomes reported in previous studies. Additional important outcomes will be sought by interviewing a group of children with Perthes' disease, adults who were treated with the disease in infancy and parents of children with the disease. This list will then be evaluated by experts in Perthes' disease using a Delphi survey divided into two rounds to ascertain the importance of each outcome. The final outcomes list obtained from the Delphi survey will be then discussed during a consensus meeting of representative key stakeholders in order to define the COS to be reported in future clinical trials related to Perthes' disease.

DISCUSSION

The absence of high-quality research and clear guidelines concerning the management of Perthes' disease is, at least in part, due to the difficulties in the comparing the results from previous studies. The development of a COS seeks to standardise outcomes collected in future research studies to enable comparisons between studies to be made and to facilitate meta-analyses of results.

TRIAL REGISTRATION

Core Outcome Measures in Effectiveness Trials Initiative (COMET), 1003 . Registered on 20 July 2017. Prospero International Prospective Register of Systematic Reviews, CRD 42017069742 . Registered on 10 July 2017.

摘要

背景

佩特兹病是一种发育性髋关节特发性骨坏死,在北欧最为常见。目前,由于缺乏一套通用的标准化结局指标,不同干预措施的研究之间难以进行比较。本研究旨在总结佩特兹病干预措施临床研究中使用的结局指标,并确定一组核心结局指标(COS),以确保在未来研究佩特兹病的研究中测量和报告最重要的变量。

方法

将对当前文献进行系统综述,以确定先前研究中报告的结局指标清单。通过采访一组佩特兹病患儿、婴儿期患该病并接受治疗的成年人以及患儿家长,寻找其他重要结局指标。然后,佩特兹病专家将使用分为两轮的德尔菲调查对该清单进行评估,以确定每个结局指标的重要性。在代表性关键利益相关者的共识会议上,将讨论从德尔菲调查中获得的最终结局指标清单,以确定未来与佩特兹病相关的临床试验中应报告的COS。

讨论

关于佩特兹病管理缺乏高质量研究和明确指南,至少部分原因是比较先前研究结果存在困难。COS的制定旨在使未来研究中收集的结局指标标准化,以便能够在研究之间进行比较,并便于对结果进行荟萃分析。

试验注册

有效性试验核心结局指标倡议(COMET),1003。于2017年7月20日注册。国际前瞻性系统评价注册库Prospero,CRD 42017069742。于2017年7月10日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54e/6044030/a0909370ee65/13063_2018_2695_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验